Novel Foamed Magnesium Phosphate Antimicrobial Bone Cement for Bone Augmentation
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2025
DOI: 10.1002/jbm.b.35492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2025. Verfasst von Jie Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Stomatology, Chongqing Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Bone Cements, Phosphates, Staphylococcus aureus, Magnesium Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Technological Rearch Program of Chongqing Yubei District.
Abstract (Originalsprache)
In dental implant surgery, infection is identified as the primary factor contributing to the failure of bone grafts. There is an urgent need to develop bone graft materials possessing antibacterial characteristics to facilitate bone regeneration. Magnesium phosphate bone cement (MPC) is highly desirable for bone regeneration due to its favorable biocompatibility, plasticity, and osteogenic capabilities. However, the limited porosity of conventional MPC hinders the nutrient supply, gas diffusion, and cell infiltration, thereby compromising its osteogenic efficacy. This research focused on the fabrication of a highly porous MPC (CaCO 3 /CA‐MPC) by incorporating citric acid (CA) and calcium carbonate (CaCO 3 ) as foaming agents. The resulting material demonstrated enhanced physicochemical properties, bioactivity, and antimicrobial effects. When compared with conventional MPC, human periodontal ligament stem cells (hPDLSCs) showed improved osteogenic differentiation when cultured with CaCO 3 /CA‐MPC. The inclusion of foaming agents significantly enhanced the antimicrobial efficacy of MPC against both Gram‐positive bacteria ( Staphylococcus aureus ) and Gram‐negative bacteria ( Escherichia coli ). The results of in vivo anti‐infection experiments in rats revealed that 3%CaCO 3 /CA‐MPC displayed superior bactericidal activity compared with Bio‐Oss and control groups ( p < 0.05), thereby enhancing the anti‐infective outcomes post‐bone grafting and stimulating osteogenesis in the infected bone defect region. The study demonstrated that MPC containing 3%CaCO 3 /CA exhibited excellent antimicrobial and osteogenic properties both in vitro and in vivo, suggesting its potential as a promising candidate as bone graft material for dental implant surgeries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Stomatology, Chongqing Medical University, Chongqing, People's Republic of China.
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Chongqing, People's Republic of China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, People's Republic of China.
ORCID-Profile: Ling Xu
Förderung
- National Natural Science Foundation of China
- Technological Rearch Program of Chongqing Yubei District
Zitieren
APA
Chen, J., Cheng, Z., Wang, J., Ding, H., Wang, K., Deng, P., Xu, L., & Huang, J. (2025). Novel Foamed Magnesium Phosphate Antimicrobial Bone Cement for Bone Augmentation. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35492
Vancouver
Chen J, Cheng Z, Wang J, Ding H, Wang K, Deng P, et al. Novel Foamed Magnesium Phosphate Antimicrobial Bone Cement for Bone Augmentation. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2025. doi:10.1002/jbm.b.35492
BibTeX
@article{Chen2025,
author = {Chen, Jie and Cheng, Ziqing and Wang, Jiawen and Ding, Huifen and Wang, Kai and Deng, Ping and Xu, Ling and Huang, Jiao},
title = {Novel Foamed Magnesium Phosphate Antimicrobial Bone Cement for Bone Augmentation},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2025},
doi = {10.1002/jbm.b.35492}
}
EUVIMED